Satellite Symposium - A Walk in the PARP: Therapeutic Strategies Targeting DNA Repair Defects in Prostate Cancer
Charles Ryan, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Todd Morgan, MD
University of Michigan
Agenda
5:30 PM - 6:00 PM Dinner and Registration
6:00 PM - 6:10 PM Welcome and Introduction
6:10 PM - 6:40 PM Practical Guidance on the Clinical Role of BRCA and Other DNA Damage Repair Genes in Prostate Cancer
6:40 PM - 7:10 PM Genetic Testing in Prostate Cancer for the Clinician
7:10 PM - 7:30 PM Targeting DNA Repair Defects in Prostate Cancer: The Role of PARP Inhibitors
7:30 PM - 8:00 PM Applying the Data to Practice: Panel Case Discussion and Audience Question and Answer Session
Join us for this dynamic, CME-certified symposium where an expert panel will review the evolving role of PARP inhibitors in prostate cancer, including an overview of DNA repair deficiencies in prostate cancer, guidance on genetic testing, an update on the latest clinical data on PARP inhibitors for the treatment of prostate cancer and future directions, and case discussions of where PARP inhibitors fit into the standard of care setting.
Goal Statement:
The goal of this activity is to improve participants’ knowledge of, confidence in, and competence in integrating PARP inhibitors into the treatment of patients with prostate cancer.
Target Audience:
This program is intended for oncologists and urologists and other healthcare providers who care for patients with prostate cancer.
Supported by educational grants from:
AstraZeneca
Clovis Oncology
Pfizer Inc.
Provided by Clinical Care Options, LLC
Joint Accreditation Statement:
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation of Credit:
Physician Continuing Education
CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest:
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Sign up now! Registration is complimentary.
Register here: https://events.clinicaloptions.com/oncology/event-list/event/?id=b1cdeb03-5129-e911-80e6-005056943d50